Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza

Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza

Scientific relevance. The development of new medicinal products to treat influenza is motivated by the limitations of existing treatment options, the emergence of drug resistance, and the health consequences of influenza epidemics associated with the highly contagious nature of the virus. Proper pla...

Full description

Saved in:
Bibliographic Details
Main Authors: A. I. Gubenko, G. V. Shukshina, A. I. Muravieva, N. E. Uvarova
Format: Article
Language:Russian
Published: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2023-12-01
Series:Регуляторные исследования и экспертиза лекарственных средств
Subjects:
infectious diseases
influenza
clinical studies
challenge trials
anti-influenza medicinal products
antivirals
Online Access:https://www.vedomostincesmp.ru/jour/article/view/400
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items